Big Tech's AI Capex Now Outruns the Cash Flow It Once Minted
The four largest hyperscalers now convert surplus cash into fixed assets faster than those assets earn, making return on capital the variable that decides this trade.
Read More
How Private Credit Is Displacing Bank Debt in Leveraged Buyouts: What It Means for Deal Valuations
<
Where April 2025 Digital Health Capital Actually Went
April 2025's biggest digital-health cheques went to diagnostics, metabolic hardware, care-operations software, and fertility infrastructure. Where value compounds next.
Read More
The GLP-1 Endgame: Value Is Migrating Off the Molecule
Lilly catches Novo, Ypsomed sells diabetes care, Virta cuts GLP-1 use, WeightWatchers files Chapter 11. Where the next decade of obesity-care value sits.
Read More
Neumarz Market Outlook January 2026
2026 M&A trends: why European and Swiss buyers are targeting US assets, plus outlook on healthcare, financial services, and energy consolidation.
Read More
The 2026 Strategic Horizon: Capital Allocation in an Era of Physical Scarcity and Fiscal Dominance
As the 2023-2025 cycle concludes, market consensus suggests a fundamental regime change. The "high nominal growth" era is giving way to a period defined by shrinking cash yields, physical resource constraints, and aggressive industrial policy.
Read More
March 2025 Financial Outlook: The Moment of Reckoning – Markets, Policy, and the Art of Staying Ahead
Markets are shifting faster than ever. Germany is spending big, America is...
Read More